HealthcareServices

Global Ribonucleic Acid (RNA) Sequencing Market Forecast 2026–2035: Long-Term Growth Insights

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ribonucleic acid (rna) sequencing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Ribonucleic Acid (RNA) Sequencing Market show for the 2026–2030 period?

The ribonucleic acid (rna) sequencing market has witnessed substantial expansion in recent years. Its value is projected to rise from $3.96 billion in 2025 to $4.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.3%. This historical growth can be attributed to several factors, including the expansion of genomics research initiatives, decreasing sequencing expenses, increased funding for academic research, wider adoption of next-generation sequencing, and a heightened demand for gene expression analysis.

The ribonucleic acid (RNA) sequencing market is anticipated to experience significant expansion over the coming years. This market is projected to reach $9.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.8%. Several factors are driving this growth during the forecast period, including the wider acceptance of precision medicine strategies, increased funding for transcriptomics research, the broadening scope of clinical diagnostic sequencing, the expanding incorporation of AI-powered data analysis, and a heightened emphasis on personalized therapeutic solutions. Key trends anticipated in the forecast period encompass the increasing embrace of single-cell RNA sequencing, a surge in the deployment of high-throughput sequencing platforms, the deeper integration of sophisticated bioinformatics tools, the widening application of clinical and translational research, and a greater commitment to ensuring data accuracy and reproducibility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What Drivers Are Shaping The Development Of The Ribonucleic Acid (RNA) Sequencing Market?

A heightened emphasis on precision medicine is anticipated to fuel the expansion of the ribonucleic acid (RNA) sequencing market in the coming years. Also known as personalized medicine, this advanced method for medical care and disease prevention takes into account each individual’s unique genetic makeup, environmental factors, and lifestyle choices. Personalized medicine offers the prospect of more effective treatments, drives advancements in genomics, helps navigate increasing disease complexity, and receives regulatory support. RNA sequencing technologies are employed to identify the sequence and measure the expression levels of RNA molecules present in a biological sample. This allows for a thorough analysis of transcriptomes, providing insights into various aspects such as gene expression patterns, alternative splicing occurrences, and RNA modifications. As an illustration, data from February 2024, sourced from the US-based non-profit organization, the Personalized Medicine Coalition, revealed that the FDA sanctioned 16 novel personalized therapies for individuals suffering from rare diseases in 2023, an increase from six approvals in 2022. Consequently, the heightened focus on precision medicine is a significant impetus for the ribonucleic acid (RNA) sequencing market.

Which Segments Are Contributing To The Growth Of The Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (rna) sequencing market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Kits, Software

2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications

4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits

3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

Which Market Trends Are Opening Growth Opportunities In The Ribonucleic Acid (RNA) Sequencing Market?

Key companies within the ribonucleic acid (RNA) sequencing market are concentrating on RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. An RNA next-generation sequencing assay functions as an advanced exome sequencing platform, leveraging sophisticated genomic sequencing technologies to analyze a patient’s complete exome. For example, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, developed for solid tumors, delivers a comprehensive analysis of the entire transcriptome, emphasizing clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering is designed to serve physicians with a specific focus on RNA fusions or altered splicing, alongside providers, researchers, and biopharma companies seeking in-depth RNA sequencing analysis of their existing samples.

Who Are The Major Companies Operating In The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (rna) sequencing market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Becton Dickinson And Company, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, QIAGEN NV, Tecan Genomics Inc, BGI Genomics Co Ltd, Takara Bio Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Macrogen Inc, Standard BioTools Inc, CD Genomics, Genewiz Inc, Novogene Co Ltd, GENEWIZ Germany GmbH, Azenta Life Sciences

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Ribonucleic Acid (RNA) Sequencing Market?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Ribonucleic Acid (RNA) Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2026, By The Business Research Company

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795